Top-News

Cannabics Pharmaceuticals News

Aktie
WKN:  A116WM ISIN:  US13764M1009 US-Symbol:  CNBXD
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
146,66 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.10.2021

Cannabics Pharmaceuticals News

31.05.22 - PR Newswire
CNBX Pharmaceuticals Release a New Corporate Presentation
CNBX Pharmaceuticals Release a New Corporate Presentation PR Newswire
05.05.22 - PR Newswire
CNBX Pharmaceuticals Granted Patent in Hong Kong
CNBX Pharmaceuticals Granted Patent in Hong Kong PR Newswire
28.03.22 - PR Newswire
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals PR Newswire
04.11.21 - PR Newswire
CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials
CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials PR Newswire
26.10.21 - PR Newswire
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago PR Newswire
25.10.21 - PR Newswire
Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors
Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire
21.10.21 - PR Newswire
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX PR Newswire
20.10.21 - PR Newswire
CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas
CNBX Director, Dr. Inbar Maymon-​Pomeranchik, to Participate at MJBizCon in Las Vegas PR Newswire
19.10.21 - PR Newswire
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021 PR Newswire
18.10.21 - PR Newswire
Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer
Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer PR Newswire
14.10.21 - PR Newswire
CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference
CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference PR Newswire
30.09.21 - PR Newswire
Cannabics Announces New Corporate Logo, New Website and New Company Presentation
Cannabics Announces New Corporate Logo, New Website and New Company Presentation PR Newswire
22.09.21 - PR Newswire
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston PR Newswire
21.09.21 - PR Newswire
Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases
Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases PR Newswire
13.09.21 - PR Newswire
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine PR Newswire
23.08.21 - PR Newswire
Hemato-Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' Board of Advisors
Hemato-​Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire
04.08.21 - PR Newswire
World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors
World-​Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire
20.07.21 - PR Newswire
Cannabics Pharmaceuticals Appoints a Second Independent Board Member
Cannabics Pharmaceuticals Appoints a Second Independent Board Member PR Newswire
07.07.21 - PR Newswire
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member PR Newswire
28.06.21 - PR Newswire
Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice PR Newswire

Newssuche

Videos

newspaper
07.05.24 +43,15%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »